Figures computed from official regulatory filings — .
Ownershipinsiders 41.12% · institutions 8.83%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NovAccess Global Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
1 buy3 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| CASSARINI JOHN | AwardD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC |
| LAIRD NEIL Jtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CASSARINI JOHN | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Anderson Jason Michael | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Morris-Irvin Dwain | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Martin Daniel G. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Morris-Irvin Dwain | Other | n/a (No price was disclosed in the filing) | SEC |
| Martin Daniel G. | Other | n/a (No price was disclosed in the filing) | SEC |
| Martin Daniel G. | Other | n/a (No price was disclosed in the filing) | SEC |
| LAIRD NEIL Jtrack record | Buy | $50K | conv 97Unusual sizeFirst in 12mo | SEC |
| LAIRD NEIL Jtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Yukich Larry Michael | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Morris-Irvin Dwain | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Martin Daniel G. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Martin Daniel G. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Martin Daniel G. | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Martin Daniel G. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DJOKOVICH TOM M | Gift | $33K | SEC |
| ANDERSON THOMAS A | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | First in 12mo | SEC |
| ALTOUNIAN BRIAN | Sell | $1M | SEC |
| ALTOUNIAN BRIAN | Sell | $405K | SEC |
| ALTOUNIAN BRIAN | Gift | $35K | SEC |
| ALTOUNIAN BRIAN | Sell | $848.5K | SEC |
| ALTOUNIAN BRIAN | Gift | $5K | SEC |